Home > Insider Trading > Filing (0001144204-15-018083)

Filing Details

Accession Number:: 0001144204-15-018083
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-24 16:06:45
Reporting Period:: 2015-03-20

Filing Date:: 2015-03-24
Accepted Time:: 2015-03-24 16:06:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1088856	Corcept Therapeutics Inc	CORT	Pharmaceutical Preparations (2834)	770487658

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1419701	L.p. Partners Venture Longitude	800 El Camino Real, Suite 220 Menlo Park CA 94025	Yes	No	Yes	No
1430719	Longitude Capital Associates, L.p.	800 El Camino Real, Suite 220 Menlo Park CA 94025	No	No	Yes	No
1430720	Longitude Capital Partners, Llc	800 El Camino Real, Suite 220 Menlo Park CA 94025	No	No	Yes	No
1431159	Juliet Bakker Tammenoms	C/O Longitude Capital Partners, Llc 800 El Camino Real, Suite 220 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-03-20	634,516	$2.77	13,145,097	No	4	X	Direct
Common Stock	Disposition	2015-03-20	300,447	$5.85	12,844,650	No	4	S	Direct
Common Stock	Acquisiton	2015-03-20	486,443	$2.77	13,331,093	No	4	X	Direct
Common Stock	Disposition	2015-03-20	230,333	$5.85	13,100,760	No	4	S	Direct
Common Stock	Acquisiton	2015-03-20	9,750	$2.77	182,742	No	4	X	Indirect	By LCA
Common Stock	Disposition	2015-03-20	4,617	$5.85	178,125	No	4	S	Indirect	By LCA
Common Stock	Acquisiton	2015-03-24	1,130,709	$2.77	14,231,469	No	4	X	Direct
Common Stock	Disposition	2015-03-24	554,348	$5.65	13,677,121	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	S	Direct
No	4	X	Direct
No	4	S	Direct
No	4	X	Indirect	By LCA
No	4	S	Indirect	By LCA
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Disposition	2015-03-20	634,516	$0.00	634,516	$2.77
Common Stock	Warrant (Right to Buy)	Disposition	2015-03-20	486,443	$0.00	486,443	$2.77
Common Stock	Warrant (Right to Buy)	Disposition	2015-03-20	9,750	$0.00	9,750	$2.77
Common Stock	Warrant (Right to Buy)	Disposition	2015-03-24	1,130,709	$0.00	1,130,709	$2.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,130,709	2008-03-25	2015-03-24	No	4	X	Direct
0	2009-02-06	2015-03-24	No	4	X	Direct
0	2009-02-06	2015-03-24	No	4	X	Indirect
0	2008-03-25	2015-03-24	No	4	X	Direct

Footnotes

Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital") and Juliet Tammenoms Bakker with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
On March 20, 2015, LVP exercised a warrant to purchase 634,516 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 300,447 of such shares to pay the exercise price and issuing to LVP the remaining 334,069 shares. In connection with such exercise, the Issuer also paid to LVP $5.63 in cash in lieu of a fractional share.
On March 20, 2015, LVP exercised a warrant to purchase 486,443 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 230,333 of such shares to pay the exercise price and issuing to LVP the remaining 256,110 shares. In connection with such exercise, the Issuer also paid to LVP $0.94 in cash in lieu of a fractional share.
Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital and Ms. Bakker with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
On March 20, 2015, LCA exercised a warrant to purchase 9,750 shares of the Issuer's common stock for an exercise price of $2.77 per share. LCA paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 4,617 of such shares to pay the exercise price and issuing to LCA the remaining 5,133 shares. In connection with such exercise, the Issuer also paid to LCA $1.95 in cash in lieu of a fractional share.
On March 24, 2015, LVP exercised a warrant to purchase 1,130,709 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 554,348 of such shares to pay the exercise price and issuing to LVP the remaining 576,361 shares. In connection with such exercise, the Issuer also paid to LVP $2.27 in cash in lieu of a fractional share.